Advertisement

Retraction Note: Decreased miR-154 expression and its clinical significance in human colorectal cancer

  • Yang Kai
  • Cheng Qiang
  • Pan Xinxin
  • Zhou Miaomiao
  • Lin KuailuEmail author
Open Access
Retraction Note
  • 91 Downloads

Retraction note: World J Surg Oncol

https://doi.org/10.1186/s12957-015-0607-5

The Editor-in-Chief is retracting this article [1] due to overlap with the following articles (amongst others) [2, 3, 4, 5, 6].

None of the authors have responded to any correspondence from the Editor-in-Chief or publisher about this retraction.

References

  1. 1.
    Kai Y, Qiang C, Xinxin P, Miaomiao Z, Kuailu L. Decreased miR-154 expression and its clinical significance in human colorectal cancer. World J Surg Oncol. 2015;13:195.CrossRefGoogle Scholar
  2. 2.
    Zhu, et al. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Diagn Pathol. 2014;(9):198 http://diagnosticpathology.biomedcentral.com/articles/10.1186/s13000-014-0198-4.
  3. 3.
    Fo, et al. MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma. OncoTargets and Therapy. 2014;7 https://www.dovepress.com/front_end/mir-206-functions-as-a-tumor-suppressor-and-directly-targets-k-ras-in%2D%2Dpeer-reviewed-article-OTT.
  4. 4.
    Tang M, et al. MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. OncoTargets Therapy. 2013;6:833–8 https://www.dovepress.com/microrna-145-downregulation-associates-with-advanced-tumor-progression-peer-reviewed-article-OTT.PubMedGoogle Scholar
  5. 5.
    Ye, et al. miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal Cancer. Plos One. 2013. https://journals.plos.org/plosone/article?id.  https://doi.org/10.1371/journal.pone.0060687.CrossRefGoogle Scholar
  6. 6.
    Sun, et al. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma. Biomed Pharmacother. 2015;71:58–63 http://www.sciencedirect.com/science/article/pii/S0753332215000633?np=y&npKey=36a5e61c240440f5c791ebb330c69e53b99cf4b599d8cf35805ed8498bb593a4.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Yang Kai
    • 1
  • Cheng Qiang
    • 2
  • Pan Xinxin
    • 1
  • Zhou Miaomiao
    • 1
  • Lin Kuailu
    • 1
    Email author
  1. 1.Department of Surgical OncologyThe First Affiliated Hospital of Wenzhou Medical CollegeWenzhouChina
  2. 2.Department of neurologyHuai’an No. 2 HospitalHuai’anChina

Personalised recommendations